Katrina L. Watson

808 total citations
18 papers, 642 citations indexed

About

Katrina L. Watson is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Katrina L. Watson has authored 18 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Katrina L. Watson's work include MicroRNA in disease regulation (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Cancer-related molecular mechanisms research (4 papers). Katrina L. Watson is often cited by papers focused on MicroRNA in disease regulation (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Cancer-related molecular mechanisms research (4 papers). Katrina L. Watson collaborates with scholars based in Canada, United States and Germany. Katrina L. Watson's co-authors include Rama Khokha, Jimmie E. Fata, Geoffrey A. Wood, Roger A. Moorehead, Carlo Hojilla, Dylan R. Edwards, Robert A. Jones, Evelyn B. Voura, Paul D. Soloway and Andrew Tri Van Ho and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Katrina L. Watson

17 papers receiving 634 citations

Peers

Countries citing papers authored by Katrina L. Watson

Since Specialization

Citations

This map shows the geographic impact of Katrina L. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina L. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina L. Watson more than expected).

Fields of papers citing papers by Katrina L. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina L. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina L. Watson. The network helps show where Katrina L. Watson may publish in the future.

Co-authorship network of co-authors of Katrina L. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina L. Watson. A scholar is included among the top collaborators of Katrina L. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina L. Watson. Katrina L. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Transgenic overexpression of the miR‐200b/200a/429 cluster prevents mammary tumor initiation in Neu/Erbb2 transgenic mice 2024 ·International Journal of Cancer ·Katrina L. Watson, Roger A. Moorehead	0
2	Loss of MXRA8 Delays Mammary Tumor Development and Impairs Metastasis 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Katrina L. Watson, Roger A. Moorehead	3
3	Elevated Expression of miR-200c/141 in MDA-MB-231 Cells Suppresses MXRA8 Levels and Impairs Breast Cancer Growth and Metastasis In Vivo 2022 ·Genes ·(unknown), Katrina L. Watson, Roger A. Moorehead	9
4	Sex Differences in Glomerular Protein Expression and Effects of Soy-Based Diet on Podocyte Signaling 2022 ·Canadian Journal of Kidney Health and Disease ·(unknown), (unknown), (unknown), Claire E. Martin, A Mitro, Peihua Lu, Laura A. New, Katrina L. Watson, Roger A. Moorehead, Nina Jones	2
5	Re-expression of miR-200s in claudin‐low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes 2021 ·Cancer Cell International ·(unknown), (unknown), Katrina L. Watson, (unknown), (unknown), Roger A. Moorehead	10
6	Transgenic overexpression of the miR-200b/200a/429 cluster inhibits mammary tumor initiation 2021 ·Translational Oncology ·Katrina L. Watson, Rui Yi, Roger A. Moorehead	4
7	Isolated Soy Protein Promotes Mammary Tumor Development Induced by the Type I Insulin-like Growth Factor Receptor in Transgenic Mice 2020 ·Nutrition and Cancer ·Katrina L. Watson, (unknown), Roger A. Moorehead	2
8	The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line 2018 ·Experimental Cell Research ·Katrina L. Watson, Robert A. Jones, (unknown), Roger A. Moorehead	25
9	Re-expression of miR-200c suppresses proliferation, colony formation andin vivotumor growth of murine claudin-low mammary tumor cells 2017 ·Oncotarget ·Robert A. Jones, Katrina L. Watson, (unknown), Sarah Nersesian, (unknown), Roger A. Moorehead	21
10	High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice 2015 ·BMC Cancer ·Katrina L. Watson, Leanne Stalker, Robert A. Jones, Roger A. Moorehead	10
11	IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development 2014 ·PLoS ONE ·Robert A. Jones, Katrina L. Watson, Craig I. Campbell, Roger A. Moorehead	4
12	Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice 2013 ·BMC Cancer ·Katrina L. Watson, Roger A. Moorehead	13
13	Type I Insulin-like Growth Factor Receptor Induces Pulmonary Tumorigenesis 2009 ·Neoplasia ·(unknown), (unknown), Craig I. Campbell, Katrina L. Watson, Jim Petrik, Jeffrey A. Whitsett, Roger A. Moorehead	17
14	Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus 2007 ·Reproduction ·Geoffrey A. Wood, Jimmie E. Fata, Katrina L. Watson, Rama Khokha	205
15	TIMP-3 Deficiency Leads to Dilated Cardiomyopathy 2004 ·Circulation ·Paul W.M. Fedak, David Smookler, Zamaneh Kassiri, Nobuhisa Ohno, Kevin J. Leco, Subodh Verma, Donald A.G. Mickle, Katrina L. Watson, Carlo Hojilla, (unknown), Richard D. Weisel, Ren‐Ke Li, Rama Khokha	134
16	Insulin-like Growth Factor-II Regulates PTEN Expression in the Mammary Gland 2003 ·Journal of Biological Chemistry ·Roger A. Moorehead, Carlo Hojilla, Ian de Belle, Geoffrey A. Wood, Jimmie E. Fata, Eileen D. Adamson, Katrina L. Watson, Dylan R. Edwards, Rama Khokha	55
17	Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. 2002 ·PubMed ·Matthias Arlt, Charlotte Kopitz, Caroline J. Pennington, Katrina L. Watson, Hans‐Willi Krell, Wolfram Bode, Bernd Gänsbacher, Rama Khokha, Dylan R. Edwards, Achim Krüger	66
18	MMP Inhibitors Augment Fibroblast Adhesion through Stabilization of Focal Adhesion Contacts and Up-regulation of Cadherin Function 2001 ·Journal of Biological Chemistry ·Andrew Tri Van Ho, Evelyn B. Voura, Paul D. Soloway, Katrina L. Watson, Rama Khokha	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact